UBS Group’s InMed Pharmaceuticals INM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2K | Buy |
7,762
+1,656
| +27% | +$5.38K | ﹤0.01% | 6985 |
|
|
2025
Q1 | $12.6K | Sell |
6,106
-4,302
| -41% | -$8.91K | ﹤0.01% | 7176 |
|
|
2024
Q4 | $49.3K | Sell |
10,408
-194
| -2% | -$920 | ﹤0.01% | 6085 |
|
|
2024
Q3 | $50.3K | Buy |
+10,602
| New | +$50.3K | ﹤0.01% | 5621 |
|
|
2024
Q2 | – | Sell |
-2
| Closed | -$15 | – | 8534 |
|
|
2024
Q1 | $15 | Buy |
+2
| New | +$15 | ﹤0.01% | 7889 |
|
|
2023
Q4 | – | Sell |
-3
| Closed | -$48 | – | 8305 |
|
|
2023
Q3 | $48 | Buy |
+3
| New | +$48 | ﹤0.01% | 7861 |
|
|
2023
Q2 | – | Sell |
-131
| Closed | -$2.83K | – | 8087 |
|
|
2023
Q1 | $2.83K | Buy |
131
+89
| +212% | +$1.92K | ﹤0.01% | 7333 |
|
|
2022
Q4 | $1.68K | Sell |
42
-248
| -86% | -$9.91K | ﹤0.01% | 8616 |
|
|
2022
Q3 | $38K | Buy |
+290
| New | +$38K | ﹤0.01% | 5533 |
|
|
2021
Q4 | – | Sell |
-10
| Closed | -$9K | – | 9237 |
|
|
2021
Q3 | $9K | Buy |
10
+6
| +150% | +$5.4K | ﹤0.01% | 6947 |
|
|
2021
Q2 | $7K | Buy |
4
+2
| +100% | +$3.5K | ﹤0.01% | 7225 |
|
|
2021
Q1 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 7475 |
|